Anorexia Nervosa and Bulimia Nervosa: How to Diagnose, Ways to Treat, and When to Triage
Anorexia Nervosa and Bulimia Nervosa: How to Diagnose, Ways to Treat, and When to Triage
Instructor: Kyla Bennett, LCSW, LSCSW
Wednesday, March 29, 2023 3:00 pm CT
Contact Hour(s): 1.0
During 2020 -2022 there has been a rise in children and teens seen in the ER with mental health problems. This has also included a rise in eating disorders. Attend this webinar to learn about comorbidities, evidence-based treatments and strategies to assist the patients and families. Eating disorders are among the deadliest mental illnesses, second only to opioid overdose. Attend this webinar to learn strategies to identify and assist your patients with eating disorders.
Registration Fee:
SPN Members: Free
Non-Members: $40
Click the button below to purchase this course. If no button appears, please log in or
create a guest account to purchase this product. Contact [email protected] for assistance.
Target Audience: Nurse educators, hospital leaders, clinical staff, and bedside nursing will all benefit from attending this webinar. As the nation navigates a pediatric behavioral health crisis, effective tools and information should be shared amongst health care professionals to ensure optimal care for this patient population is provided. Learn how a hospital created the Behavioral Response Team, the roles within the department, crisis management and the new model of proactive care provided in non-psychiatric settings.
Outcome: 75% of the participants will identify a new strategy or validate a current strategy which will assist clients with eating disorders.
Continuing Education: Society of Pediatric Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Successful Completion:
1. View Webinar
2. Complete online course evaluation and attestation of completion
Relevant Financial Relationships:
Planners and faculty for this educational event, have no relevant financial relationship(s) with ineligible companies to disclose.